I think that the 10 year thing is a comment on how long it will take to become affordable for the average joe.
The guy who did the interview with Tsuji just 2 weeks ago states that they have already started in humans and it will be available, but very expensive, in 2020/21.
He also took a...
The article that Joxy posted states that it was an autologous transplant i.e. his own cells. They "transplanted olfactory mucosal cells drawn from his upper nasal passages".
Replicel is definitely unproven, given what only 10 or so patients were followed up on in the 5 year window? The new...
Sorry for asking something that can be found elsewhere but I'm having difficulty determining if the trial duration is 12 months or 24?
Like, in terms of follow up with the ~60 whatever patients, is it only after 12 months they check efficacy? Or also at the 24 month mark?
Thanks
I've taken them for almost a year now, 2x a day. Recommended by a great doctor I saw who really went the extra mile in looking into non-prescription level treatments.
Hey all,
Sorry this must have been covered many times in this section, but what blood tests do you recommend before trying out finasteride for the first time?
Is it called something along the lines of a "baseline serum hormone test"? My general practitioner didn't know of any blood-work that can be...
I appreciate your posts because they are based off of logic and not full emotion. And then when some new information comes up, your position is open to change. So yeah, hats off.
Bit of a chicken and egg argument. They could have changed it because everyone here and on IESON was loosing their sh*t, and calling them lairs, so they backtracked to cover their ***, regardless of what they think it can do.
I think this is overly pessimistic. But the lesson from this experience is that the conversion from clinical trial to analysis of results to decisions over commercialization to actual commercialization takes way longer than what, a year?
Tsuji in 2020 is pretty unrealistic. Hold onto your...
The fact we don't have data yet is no reflection on the outcome of the trials.
And no, Shiseido's stock isn't going to tumble if the results are poorer than we all hope here. Success and failure in R&D at conglomerates are business as usual, and don't affect the fundamentals of the company.